unknown
Stage
About
Uncommon Therapeutics is a San Francisco-based biotech developing gene-therapy and CRISPR-based polytherapy treatments for Rett syndrome and other genetic diseases. The company was founded after the founder's daughter was diagnosed with Rett syndrome and has designed multiple therapeutic candidates using a polytherapy strategy.
Explore Uncommon Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.